Insider Transactions in Q2 2021 at Macrogenics Inc (MGNX)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 24
2021
|
Ezio Bonvini Sr VP, Research & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
26,076
+10.53%
|
$469,368
$18.27 P/Share
|
|
Jun 21
2021
|
Target N V Biotech > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
75,000
+1.18%
|
$1,575,000
$21.74 P/Share
|
|
Jun 16
2021
|
Target N V Biotech > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
100,000
+1.59%
|
$2,100,000
$21.04 P/Share
|
|
Jun 15
2021
|
Target N V Biotech > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
75,000
+1.21%
|
$1,500,000
$20.53 P/Share
|
|
May 14
2021
|
Ezio Bonvini Sr VP, Research & CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,416
-2.85%
|
$70,064
$29.49 P/Share
|
|
May 14
2021
|
Ezio Bonvini Sr VP, Research & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+5.56%
|
-
|
|
Apr 15
2021
|
Thomas Spitznagel Sr VP, Technical Ops |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$150,000
$30.91 P/Share
|
|
Apr 15
2021
|
Thomas Spitznagel Sr VP, Technical Ops |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$35,000
$7.51 P/Share
|